124 related articles for article (PubMed ID: 77840)
1. Target cell - substratum interaction. I. Effect of primed lymphocytes on a rat mammary adenocarcinoma tumor cell line.
David GS; Wiglesworgh CM
Immunol Commun; 1978; 7(3):337-52. PubMed ID: 77840
[TBL] [Abstract][Full Text] [Related]
2. Immune response to a mammary adenocarcinoma. IV. Blocking of cell-mediated cytolysis by immunoglobulins binding to immune lymphocytes.
Huber SA; Lucas ZJ
J Immunol; 1977 Aug; 119(2):726-36. PubMed ID: 328781
[No Abstract] [Full Text] [Related]
3. Immune response to a mammary adenocarcinoma. VI. Blocking of tumor-specific cell-mediated cytotoxicity by antibodies to the cytotoxic lymphocyte.
Huber SA; Lucas ZJ
J Immunol; 1978 Dec; 121(6):2490-6. PubMed ID: 309904
[No Abstract] [Full Text] [Related]
4. Immune response to a syngeneic mammary adenocarcinoma. II. In vitro generation of cytotoxic lymphocytes.
Kuperman O; Fortner GW; Lucas ZJ
J Immunol; 1975 Nov; 115(5):1277-81. PubMed ID: 51887
[TBL] [Abstract][Full Text] [Related]
5. Immune response to a syngeneic mammary adenocarcinoma. III. Development of memory and suppressor functions modulating cellular cytotoxicity.
Kuperman O; Fortner GW; Lucas ZJ
J Immunol; 1975 Nov; 115(5):1282-7. PubMed ID: 1176776
[TBL] [Abstract][Full Text] [Related]
6. Target cell-substratum interaction. II. Complement-dependent antibody-induced inhibition of adherence.
David GS; Wiglesworth CM
J Immunol; 1977 Aug; 119(2):500-3. PubMed ID: 328775
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of in vitro lymphoproliferative responses by in vivo passaged rat 13762 mammary adenocarcinoma cells. I. Characteristics of inhibition and evidence for an infectious agent.
Campbell DA; Manders EK; Oehler JR; Bonnard GD; Oldham RK; Herberman RB
Cell Immunol; 1977 Oct; 33(2):364-77. PubMed ID: 144021
[No Abstract] [Full Text] [Related]
8. Distinct T-cell proliferative responses to 13762A rat mammary adenocarcinoma and derived clones.
Christensen ND; Kreider JW; Bartlett GL; Horetsky RL
Cell Immunol; 1986 Feb; 97(2):433-45. PubMed ID: 3091274
[TBL] [Abstract][Full Text] [Related]
9. An innate host response to the neoplastic cell: syngeneic rat tumor cells can elicit a rapid de novo lymphoid procoagulant response.
Lando PA; Edgington TS
J Immunol; 1985 Nov; 135(5):3587-95. PubMed ID: 4045197
[TBL] [Abstract][Full Text] [Related]
10. Systemic adoptive transfer of immunity to 13762A rat mammary adenocarcinoma.
Boyer CM; Kreider JW; Bartlett GL
Cancer Res; 1981 Jun; 41(6):2394-400. PubMed ID: 6972251
[TBL] [Abstract][Full Text] [Related]
11. A quantitative assay for tumor antigen based on inhibition of cytotoxicity of sensitized lymphocytes.
Huber S; Lucas ZJ
Int J Cancer; 1979 Feb; 23(2):224-32. PubMed ID: 83968
[TBL] [Abstract][Full Text] [Related]
12. Specific tumor-induced suppression of lymphocyte activity in the antibody-dependent tumoricidal reaction.
Stolfi RL; Stolfi LM; Fugmann RA; Martin DS
Int J Cancer; 1974 Nov; 14(5):625-32. PubMed ID: 4142474
[No Abstract] [Full Text] [Related]
13. Tumor antigen extracts stimulate cytotoxicity against unrelated target cells.
Lopez DM; Sigel MM
Int J Cancer; 1976 Dec; 18(6):808-12. PubMed ID: 992908
[TBL] [Abstract][Full Text] [Related]
14. Studies on effector cell-target cell interactions in vitro by means of the quantitative immunoadherence technique.
Doljanski F; Markson Y; Katzav S; Weiss DW
Adv Exp Med Biol; 1976; 66():437-43. PubMed ID: 57704
[No Abstract] [Full Text] [Related]
15. A micro-colony-inhibition method for quantitation of tumor immunity.
Haskill JS
J Natl Cancer Inst; 1973 Nov; 51(5):1581-8. PubMed ID: 4762935
[No Abstract] [Full Text] [Related]
16. Inhibition of in vitro lymphoproliferative responses by in vivo passaged rat 13762 mammary adenocarcinoma cells. II. Evidenceth Kilham rat virus is responsible for the inhibitory effect.
Campbell DA; Staal SP; Manders EK; Bonnard GD; Oldham RK; Salzman LA; Herberman RB
Cell Immunol; 1977 Oct; 33(2):378-91. PubMed ID: 912764
[No Abstract] [Full Text] [Related]
17. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
Lopez PF; Parks WP; Lopez DM
J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
[TBL] [Abstract][Full Text] [Related]
18. Differences in kinetic parameters of lysis by syngeneic and allogeneic T lymphocytes immune to the same tumor.
Huber SA; Lucas ZJ
J Immunol; 1978 Dec; 121(6):2270-7. PubMed ID: 309897
[No Abstract] [Full Text] [Related]
19. Host responses within solid tumors: non-thymus-derived specific cytotoxic cells within a murine mammary adenocarcinoma.
Haskill JS; Yamamura Y; Radov L
Int J Cancer; 1975 Nov; 16(5):798-809. PubMed ID: 1081078
[TBL] [Abstract][Full Text] [Related]
20. Immunologic control of the ascites of murine adenocarcinoma 755. I. Protection with syngeneic immune serum or lymphoid cells.
Haagensen DE; Roloson G; Collins JJ; Wells SA; Bolognesi DP; Hansen HJ
J Natl Cancer Inst; 1978 Jan; 60(1):131-9. PubMed ID: 628013
[No Abstract] [Full Text] [Related]
[Next] [New Search]
